GLPG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Galapagos NV (GLPG) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the company has shown impressive financial growth in the latest quarter and has a positive long-term outlook with cash flow neutrality expected by the end of 2026, the current technical indicators and market sentiment do not support an immediate entry point. The stock is trading near its support level with a negative MACD and RSI in the neutral zone, suggesting no clear upward momentum. Additionally, the options data indicates a bearish sentiment with a high open interest put-call ratio. For now, it is advisable to hold off on investing until there are stronger technical or sentiment signals.
The MACD is negative and expanding downward (-0.071), indicating bearish momentum. RSI is neutral at 38.432, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 33.182), with resistance at 34.409. Overall, the technical indicators suggest a lack of upward momentum.
Exceptional financial growth in FY 2023, with revenue up 302.8% YoY and net income up 2990.63% YoY.
Positive long-term outlook with cash flow neutrality expected by the end of
Successful completion of a pivotal Phase 3 study, enhancing market prospects for rare disease treatments.
Anticipated operating cash outflows of up to €50 million in Q1 2026 due to restructuring costs.
Cash costs of up to €40 million in 2026 for the TYK2 program.
Revenue decline of 70.7% YoY in Q4 2023, despite positive EPS growth.
Galapagos NV reported exceptional financial growth in FY 2023, with revenue increasing by 302.8% YoY to €1.11 billion. In Q4 2025, revenue grew by 1093.22% YoY, net income surged by 2990.63% YoY, and EPS rose by 3023.68% YoY. Gross margin also improved to 99.95%, up 26.28% YoY. However, the company anticipates significant cash outflows in 2026 for restructuring and clinical trials.
No recent analyst rating or price target changes are available for analysis.
